Yayınlar & Eserler

Yayın Ağı
Makaleler 3
Tümü (3)
SCI-E, SSCI, AHCI, ESCI (2)
ESCI (2)
TRDizin (2)

1. Genetic heterogeneity and metabolic reprogramming in breast cancer

DOLAŞ Y., BURUŞ A., ÇELTİKÇİ B.
Acta Medica , cilt.55, sa.4, ss.1-20, 2024 (TRDizin)

2. The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.
INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES , cilt.14, sa.2, ss.1-14, 2024 (ESCI) identifier

3. Cross Talk Between Genetics and Biochemistry in The Pathogenesis of Hepatocellular Carcinoma

ÜÇDAL M. T., BURUŞ A., ÇELTİKÇİ B.
Hepatology forum , cilt.5, sa.3, ss.150-160, 2024 (ESCI, TRDizin) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?

RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.
41. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 27 Kasım 2024, (Özet Bildiri)

2. Two forms of a disease in the same family: compound heterozygosity in the father and his sister both with corneal cystinosis, and heterozygous daughter and his other sister both having risks for nephropathic cystinosis

ÇELTİKÇİ B., Kazancı B.
European Human Genetics Virtual Conference, Berlin, Almanya, 06 Haziran 2020, (Tam Metin Bildiri)

3. Two families having Huntington’xxs disease with two different clinical presentations

ÇELTİKÇİ B., Kaplan F., SAYIN R.
EUROPEAN HUMAN GENETICS CONFERENCE, Gothenburg, İsveç, 15 - 18 Haziran 2019, cilt.27, ss.1865, (Tam Metin Bildiri)

4. The effects of human chorionic gonadotropin-based hormonal therapy on the expression levels of proliferating cell nuclear antigen

ÇELTİKÇİ B., TANGAL S., ÖZER L.
13. Balkan Congress of Human Genetics, 17 - 20 Nisan 2019, (Tam Metin Bildiri)

5. The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF-mutant colorectal cancer cell lines.

ÇELTİKÇİ B., Carson R., Johnston P. G., Van Schaeybroeck S.
JOURNAL OF CLINICAL ONCOLOGY, Chicago, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma

6. The role of JAK1/2-STAT3 as acute resistance mechanism to MEK inhibition in BRAF mutant colorectal cancer

Carson R., ÇELTİKÇİ B., Johnston P. G., Van Schaeybroeck S., Dunne P.
MOLECULAR CANCER THERAPEUTICS, 10 - 13 Kasım 2013, cilt.12 Sürdürülebilir Kalkınma

7. The establishment of Green Fluorescent Protein expressing CHO cells by stable transfection using activated dendrimers and G418 selection

ÇELTİKÇİ B., ÖZKARA H. A., PURALI N.
FEBS JOURNAL, Prague, 4 - 09 Temmuz 2009, cilt.276, ss.215-216

8. Increased hexosaminidase activity in psychiatric patients with drug induced extrapramidal side effects

Tunca Z., Resmi H., Ozkara A., Ciliv G., Celtikci B., Alptekin K., et al.
62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry, California, Amerika Birleşik Devletleri, 01 Ocak 2007, cilt.61, (Özet Bildiri) identifier

9. Protective role of 27 bp deletion polymorphism in intron 4 of eNOS gene in cerebral small-vessel disease

Yemisci M., Sinici I., ÖZKARA H. A., HAYRAN K. M., ay h., ÇELTİKÇİ B., et al.
FEBS JOURNAL, İstanbul, Türkiye, 24 - 29 Haziran 2006
Metrikler

Yayın

23

Yayın (WoS)

13

Yayın (Scopus)

10

Atıf (WoS)

103

H-İndeks (WoS)

5

Atıf (Scopus)

136

H-İndeks (Scopus)

6

Atıf (Scholar)

1

H-İndeks (Scholar)

1

Proje

8

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları